← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Evodenovo, Inc.
Andover, MA
$2,230,338
Total funding
2
Grants
Funding over time
peak $1.1M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,230,338 · 2
By mechanism
R44$1,975,277 · 1
R43$255,061 · 1
Investigators at Evodenovo, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of small molecule therapeutics for mitigating opioid withdrawal syndrome$1,094,320
R44 · FY2025 · DA
Development of small molecule therapeutics for mitigating opioid withdrawal syndrome$880,957
R44 · FY2024 · DA
Identification of Cyclic Peptide Antagonists of an Anti-Opioid G Protein-Coupled Receptor$255,061
R43 · FY2022 · DA